Neurocrine Biosciences (NBIX) Current Leases (2010 - 2017)
Neurocrine Biosciences (NBIX) reported Current Leases of $62000.0 for Q4 2017, down 73.73% on a YoY basis from $236000.0 in Q4 2016, and down 48.76% quarter-over-quarter from $121000.0 in Q3 2017.
Neurocrine Biosciences (NBIX) Current Leases (2010 - 2017) Analysis & Trends
Neurocrine Biosciences has reported Current Leases for 8 years, with the latest figure at $62000.0 in Q4 2017.
- For the quarter ending Q4 2017, Current Leases fell 73.73% year-over-year to $62000.0; the trailing twelve-month figure through Dec 2017 stood at $62000.0 (down 73.73% YoY), and the FY2017 full-year result was $62000.0, down 73.73% from the prior year.
- Current Leases for Q4 2017 stood at $62000.0, down from $121000.0 in the prior quarter.
- The five-year high for Current Leases was $556000.0 in Q2 2015, with the low at $62000.0 in Q4 2017.
- Historically, Current Leases has averaged $352900.0 across 5 years, with a median of $412500.0 in 2013.
- Annual changes were most pronounced in 2013 — Current Leases jumped 84.39% — and 2017, when it plunged 73.73%.
- Neurocrine Biosciences' Current Leases stood at $416000.0 in 2013, then rose by 12.26% to $467000.0 in 2014, then slipped by 8.35% to $428000.0 in 2015, then sank by 44.86% to $236000.0 in 2016, then sank by 73.73% to $62000.0 in 2017.
- The last three Current Leases figures came in at $62000.0 (Q4 2017), $121000.0 (Q3 2017), and $181000.0 (Q2 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 5.58 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 807,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 62,000.00 |
| Sep 30, 2017 | 121,000.00 |
| Jun 30, 2017 | 181,000.00 |
| Mar 31, 2017 | 243,000.00 |
| Dec 31, 2016 | 236,000.00 |
| Sep 30, 2016 | 265,000.00 |
| Jun 30, 2016 | 259,000.00 |
| Mar 31, 2016 | 234,000.00 |
| Dec 31, 2015 | 428,000.00 |
| Sep 30, 2015 | 481,000.00 |
| Jun 30, 2015 | 556,000.00 |
| Mar 31, 2015 | 479,000.00 |
| Dec 31, 2014 | 467,000.00 |
| Sep 30, 2014 | 454,000.00 |
| Jun 30, 2014 | 441,000.00 |
| Mar 31, 2014 | 428,000.00 |
| Dec 31, 2013 | 416,000.00 |
| Sep 30, 2013 | 409,000.00 |
| Jun 30, 2013 | 402,000.00 |
| Mar 31, 2013 | 496,000.00 |